RecruitingNCT05883137

High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill

High-flow Nasal Oxygenation for Apnoeic Oxygenation With Optiflow Switch During Intubation of the Critically Ill Adult- a Prospective Before-and-after Study


Sponsor

Region Stockholm

Enrollment

150 participants

Start Date

Sep 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Intubation in the intensive care unit is a standard procedure with a high risk of adverse events such as hypoxaemia and cardiovascular instability. However, it is demonstrated that HFNO (High Flow Nasal Oxygen) for pre and perioxygenation is feasible and, in many situations, prolongs the safe apnoeic period after anaesthesia induction. Previous data of the use of HFNO during intubation of the critically ill is conflicting. With the new device Optiflow Switch, which allow its combination with NIV or tight facemask with perioxygenation, we aim to evaluate whether this could reduce intubation-related hypoxaemia and other adverse events. The general purpose of this project is to compare the addition of Optiflow Switch for pre- and perioxygenation to traditional preoxygenation using a tight-fitting mask or NIV during intubation in adult intensive care patients in a prospective before-and-after study design.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria2

  • Adult, ≥18 years old
  • Intensive care patients that require tracheal intubation for any indication

Exclusion Criteria4

  • Patients with skull or facial injuries where the application of nasal cannula is to be avoided, decided by the intensivist.
  • Pregnancy
  • Total nasal obstruction
  • Deemed not suitable for any other reason than the aforementioned

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOptiflow Switch

High flow nasal oxygen with the Optiflow Switch device


Locations(1)

Karolinska University Hospital

Stockholm, Stockholm County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05883137


Related Trials